Starting Ph.D. research at Institute of Environmental Medicine, Karolinska Institutet from January 2018, my doctoral thesis mainly focuses on the role of human gut microbiome alteration on the risk of amyotrophic lateral sclerosis (ALS).
Before that, I obtained my master's degree in Epidemiology and Biostatistics from the Fudan University, China in June 2016 and then worked as a biostatistician in Johnson & Johnson (China) Investments Ltd., Shanghai, China.
I excel at managing and analyzing real-world big data by using SAS. Other software including STATA, R, or Python works for me as well. I first-authored a book (only have Chinese version) to introduce the health-workers to these four commonly used software from basic coding to advanced use. This book has been published by Tsinghua University Press in June 2021 (No. of pages: 623).
Link to this book: http://www.tup.tsinghua.edu.cn/booksCenter/book_08647801.html
The research questions of my doctoral thesis include for example whether individuals with antibiotics use or patients with a gastrointestinal biopsy test have a consequent higher risk of developing ALS, whether gut microbiome is altered in patients with ALS compared with controls, whether altered gut microbiome affect ALS prognosis, and biomarkers for ALS prognosis.
Except for ALS, I also did several research projects about other neurodegenerative diseases, such as Parkinson's disease and Alzheimer's disease.
Different study designs (e.g., matched cohort study, matched case-control study, longitudianl study, and case-control study) in various datasets (e.g., Swedish health registers, Stockholm CREAtinine Measurement (SCREAM) project, nationwide gastrointestinal ESPRESSO histopathology cohort, and ALSrisc study) are applied to answer the aforementioned questions.
Master of Public Health, Fudan University